Teenagers from 15 should be given MenB vaccine, say UK experts after Kent outbreak
Advisers are asking the government to consider introducing the jabs following concerns over a meningitis B outbreak in Kent earlier this year, in which two people died.
The recommendation by UK experts to vaccinate teenagers against MenB, a type of meningitis, is a significant development in the country's efforts to prevent the spread of the disease. The outbreak in Kent earlier this year, which resulted in two fatalities, has highlighted the need for increased protection against this potentially deadly infection. Meningitis B is a leading cause of bacterial meningitis and septicemia in young people, and vaccination has been shown to be an effective way to prevent its spread.
The proposed vaccination program would target 15-year-olds, a key age group that is often affected by the disease. The UK's Joint Committee on Vaccination and Immunisation (JCVI) has been monitoring the situation closely and is now advising the government to consider introducing the jabs. If implemented, this would bring the UK in line with other countries that already offer MenB vaccination to teenagers. The move is likely to be seen as a positive step by public health experts and parents, who have been calling for increased action to prevent meningitis B.
As the government considers the JCVI's recommendation, there are several factors to watch next. One key question is whether the government will make the MenB vaccine a compulsory part of the national immunization program, or whether it will be offered on an opt-in basis. Additionally, there will be interest in how the vaccination program is rolled out, and how it will be funded. With the JCVI's recommendation now on the table, the next few weeks and months will be crucial in determining the future of MenB vaccination policy in the UK.
Originally reported by bbc.co.uk. MyNews adds analysis for general news readers.